May 14 (Reuters)- Kidswell Bio Corporation CONSOLIDATED FINANCIAL HIGHLIGHTS (in billions of yen unless specified) Year ended Year ended Year to NEXT Mar 31, 2026 Mar 31, 2025 Mar 31, 2027 YEAR LATEST YEAR-AGO COMPANY COMPANY RESULTS RESULTS FORECAST H1 FORECAST Sales 6.59 5.08 (+29.7 pct) Operating loss 138 mln 27 mln Recurring loss 374 mln 5 mln Net Net loss 413 mln loss 21 mln EPS loss 8.48 yen loss 0.52 yen Ann Div NIL NIL NIL -Q2 Div NIL NIL NIL -Q4 Div NIL NIL NIL NOTE - Kidswell Bio Corporation. *Second Net profit row denotes profit attributable to owners ofthe parent To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4584.T